What is the Jenburkt Pharmaceuticals Ltd share price today?

The share price of NSE:JENBURPH-EQ on 01 Oct 2026 (as of 15:03:56 IST) is ₹924.

What is the NSE:JENBURPH-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:JENBURPH-EQ 52 week high low range shows a high of ₹1073.9 and a low of ₹911.1.

What is the Jenburkt Pharmaceuticals Ltd market cap?

As on 01 Oct 2026, Jenburkt Pharmaceuticals Ltd market cap is ₹4049860000.

What is the shareholding pattern of Jenburkt Pharmaceuticals Ltd Stock?

The shareholding pattern of Jenburkt Pharmaceuticals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 46.62% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0.12% Mutual Funds: 0% Retail & Others: 53.26% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Jenburkt Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Jenburkt Pharmaceuticals Ltd is 12.3362, and the Price-to-Book (PB) ratio is 2.14, as on 01 Oct 2026.

Jenburkt Pharmaceuticals Share Price

900.00+40.00 (+4.65%)

-29.30% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+4.65%

1 Week

+3.93%

1 Month

-2.74%

3 Month

-22.55%

6 Month

-23.06%

YTD

-17.42%

1 Year

-29.30%

5 Year

+60.97%

10 Year

Max

+82.19%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

895.00

848.05

High

911.90

1045.00

1191.90

1245.00

1317.00

About

Jenburkt Pharmaceuticals Limited is an India-based company engaged pharmaceutical formulations. The Company is engaged in manufacturing and marketing of speciality and pharmaceutical formulations and healthcare products. The Company manufactures products Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMA-ANSE

DIVISLAB-ANSE

TORNTPHARM-ANSE

LAURUSLABS-ANSE

ZYDUSLIFE-ANSE

DRREDDY-ANSE

CIPLA-ANSE

MANKIND-ANSE

AUROPHARMA-ANSE

LUPIN-ANSE

JENBURPH-BNSE

LTP

1W Low

1W High

Market cap (₹)

1771.95+9 (0.51%)

1720.80

1854.80

4,24,202Cr

10030+375 (3.88%)

9622.85

10035

2,64,141Cr

4635+70.9 (1.55%)

4555

4668.55

1,74,402Cr

2320+75 (3.34%)

2207.10

2442

1,26,811Cr

1239+53 (4.47%)

1184.55

1264.20

1,23,685Cr

1370+31.5 (2.35%)

1337.30

1390.70

1,11,868Cr

1392.2+35.2 (2.59%)

1360.60

1392.20

1,11,650Cr

2477.1+15.9 (0.65%)

2457.35

2527.80

1,02,196Cr

1699+44 (2.66%)

1650.10

1699

96,951Cr

2012+14 (0.70%)

1974.05

2032

91,301Cr

900+34 (3.93%)

848.05

911.90

380Cr

Jenburkt Pharmaceuticals Share Price

900.00+40.00 (+4.65%)

-29.30% past 1 Year

Financial overview

Compounded Sales Growth

10 years6%

5 years9%

3 years7%

Last year11%

Compounded Profit Growth

10 years12%

5 years16%

3 years12%

Last year8%

Stock Price CAGR

10 years-

5 years9%

3 years11%

1 year-32%

Return on Equity

10 years22%

5 years20%

3 years20%

Last year19%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
6%	9%	7%	11%
12%	16%	12%	8%
-	9%	11%	-32%
22%	20%	20%	19%

Peer Comparison

Symbol

SUNPHARMA-A

DIVISLAB-A

TORNTPHARM-A

LAURUSLABS-A

ZYDUSLIFE-A

DRREDDY-A

CIPLA-A

MANKIND-A

AUROPHARMA-A

LUPIN-A

JENBURPH-B

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,774.9	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
9,887.5	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,613.5	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,256.75	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,236.8	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,353.4	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,383.9	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,475.2	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,668	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,007	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
860	₹380 Cr	11.56	13.34	81.25	₹35 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Mar 2018	Dec 2017	Sep 2017	Jun 2017	Mar 2017	Dec 2016	Sep 2016	Jun 2016	Mar 2016	Dec 2015	Sep 2015	Jun 2015	Mar 2015	Dec 2014	Sep 2014	Jun 2014	Mar 2014	Dec 2013	Sep 2013	Jun 2013	Mar 2013	Dec 2012	Sep 2012
₹36 Cr	₹45 Cr	₹43 Cr	₹46 Cr	₹36 Cr	₹41 Cr	₹37 Cr	₹41 Cr	₹33 Cr	₹39 Cr	₹36 Cr	₹38 Cr	₹29 Cr	₹35 Cr	₹35 Cr	₹36 Cr	₹31 Cr	₹28 Cr	₹33 Cr	₹36 Cr	₹27 Cr	₹30 Cr	₹32 Cr	₹30 Cr	₹17 Cr	₹30 Cr	₹34 Cr	₹34 Cr	₹21 Cr	₹35 Cr	₹32 Cr	₹32 Cr	₹23 Cr	₹30 Cr	₹31 Cr	₹37 Cr	₹17 Cr	₹27 Cr	₹25 Cr	₹29 Cr	₹22 Cr	₹22 Cr	₹24 Cr	₹25 Cr	₹22 Cr	₹22 Cr	₹21 Cr	₹22 Cr	₹19 Cr	₹20 Cr	₹19 Cr	₹20 Cr	₹17 Cr	₹17 Cr	₹18 Cr	₹20 Cr
₹2 Cr	₹4 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹98 L	₹1 Cr	₹83 L	₹86 L	₹1 Cr	₹93 L	₹67 L	₹91 L	₹91 L	₹65 L	₹69 L	₹94 L	₹1 Cr	₹89 L	₹66 L	₹63 L	₹73 L	₹88 L	₹67 L	₹60 L	₹59 L	₹2 Cr	₹18 L	₹24 L	₹6 L	₹74 L	₹52 L	₹37 L	₹1 L	₹56 L	₹37 L	₹12 L
₹37 Cr	₹49 Cr	₹45 Cr	₹48 Cr	₹38 Cr	₹43 Cr	₹38 Cr	₹43 Cr	₹34 Cr	₹40 Cr	₹37 Cr	₹39 Cr	₹30 Cr	₹36 Cr	₹36 Cr	₹37 Cr	₹32 Cr	₹30 Cr	₹34 Cr	₹37 Cr	₹28 Cr	₹31 Cr	₹33 Cr	₹32 Cr	₹18 Cr	₹32 Cr	₹34 Cr	₹35 Cr	₹22 Cr	₹36 Cr	₹33 Cr	₹33 Cr	₹24 Cr	₹31 Cr	₹32 Cr	₹38 Cr	₹18 Cr	₹28 Cr	₹26 Cr	₹29 Cr	₹23 Cr	₹23 Cr	₹25 Cr	₹26 Cr	₹23 Cr	₹24 Cr	₹22 Cr	₹22 Cr	₹19 Cr	₹21 Cr	₹20 Cr	₹20 Cr	₹17 Cr	₹18 Cr	₹18 Cr	₹20 Cr
₹30 Cr	₹31 Cr	₹36 Cr	₹33 Cr	₹27 Cr	₹31 Cr	₹29 Cr	₹30 Cr	₹24 Cr	₹30 Cr	₹29 Cr	₹30 Cr	₹23 Cr	₹28 Cr	₹28 Cr	₹28 Cr	₹24 Cr	₹24 Cr	₹27 Cr	₹26 Cr	₹22 Cr	₹25 Cr	₹25 Cr	₹24 Cr	₹17 Cr	₹25 Cr	₹28 Cr	₹27 Cr	₹22 Cr	₹27 Cr	₹26 Cr	₹25 Cr	₹21 Cr	₹22 Cr	₹25 Cr	₹25 Cr	₹21 Cr	₹22 Cr	₹21 Cr	₹22 Cr	₹20 Cr	₹20 Cr	₹20 Cr	₹20 Cr	₹19 Cr	₹19 Cr	₹18 Cr	₹18 Cr	₹17 Cr	₹18 Cr	₹17 Cr	₹17 Cr	₹15 Cr	₹15 Cr	₹16 Cr	₹16 Cr
₹8 Cr	₹19 Cr	₹9 Cr	₹15 Cr	₹11 Cr	₹13 Cr	₹10 Cr	₹13 Cr	₹11 Cr	₹11 Cr	₹9 Cr	₹10 Cr	₹8 Cr	₹9 Cr	₹8 Cr	₹10 Cr	₹8 Cr	₹6 Cr	₹8 Cr	₹11 Cr	₹7 Cr	₹6 Cr	₹8 Cr	₹8 Cr	₹2 Cr	₹8 Cr	₹7 Cr	₹8 Cr	₹62 L	₹10 Cr	₹7 Cr	₹8 Cr	₹4 Cr	₹9 Cr	₹7 Cr	₹13 Cr	-₹2 Cr	₹7 Cr	₹5 Cr	₹8 Cr	₹3 Cr	₹4 Cr	₹6 Cr	₹6 Cr	₹4 Cr	₹6 Cr	₹4 Cr	₹5 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹4 Cr
₹13 L	₹13 L	₹12 L	₹11 L	₹11 L	₹11 L	₹11 L	₹12 L	₹12 L	₹6 L	₹7 L	₹7 L	₹7 L	₹8 L	₹10 L	₹9 L	₹9 L	₹12 L	₹10 L	₹11 L	₹10 L	₹12 L	₹12 L	₹12 L	₹11 L	₹12 L	₹14 L	₹19 L	₹7 L	₹10 L	₹11 L	₹9 L	₹9 L	₹13 L	₹11 L	₹9 L	₹9 L	₹13 L	₹9 L	₹11 L	₹9 L	₹12 L	₹8 L	₹7 L	₹10 L	₹9 L	₹10 L	₹5 L	₹12 L	₹0	₹58 L	₹21 L	₹50 L	₹36 L	₹8 L	₹26 L
₹7 Cr	₹14 Cr	₹8 Cr	₹14 Cr	₹10 Cr	₹12 Cr	₹10 Cr	₹13 Cr	₹10 Cr	₹10 Cr	₹8 Cr	₹10 Cr	₹7 Cr	₹8 Cr	₹8 Cr	₹9 Cr	₹8 Cr	₹5 Cr	₹8 Cr	₹11 Cr	₹6 Cr	₹6 Cr	₹7 Cr	₹8 Cr	₹100 L	₹7 Cr	₹7 Cr	₹8 Cr	₹2 L	₹9 Cr	₹7 Cr	₹8 Cr	₹3 Cr	₹9 Cr	₹7 Cr	₹13 Cr	-₹3 Cr	₹6 Cr	₹4 Cr	₹7 Cr	₹3 Cr	₹3 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹3 Cr
₹6 Cr	₹11 Cr	₹6 Cr	₹10 Cr	₹8 Cr	₹9 Cr	₹7 Cr	₹10 Cr	₹7 Cr	₹8 Cr	₹5 Cr	₹7 Cr	₹5 Cr	₹6 Cr	₹5 Cr	₹7 Cr	₹6 Cr	₹3 Cr	₹6 Cr	₹8 Cr	₹5 Cr	₹4 Cr	₹6 Cr	₹6 Cr	₹1 Cr	₹5 Cr	₹5 Cr	₹6 Cr	₹6 L	₹7 Cr	₹4 Cr	₹6 Cr	₹3 Cr	₹6 Cr	₹5 Cr	₹10 Cr	-₹3 Cr	₹4 Cr	₹3 Cr	₹5 Cr	₹2 Cr	₹1 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹94 L	₹2 Cr	₹1 Cr	₹2 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr
₹193 Cr	₹167 Cr	₹141 Cr	₹118 Cr	₹113 Cr	₹94 Cr	₹75 Cr	₹73 Cr	₹57 Cr	₹50 Cr	₹36 Cr	₹29 Cr	₹23 Cr	₹18 Cr	₹14 Cr	₹10 Cr	₹6 Cr	₹4 Cr	₹3 Cr
₹193 Cr	₹167 Cr	₹141 Cr	₹118 Cr	₹113 Cr	₹94 Cr	₹75 Cr	₹73 Cr	₹57 Cr	₹50 Cr	₹36 Cr	₹29 Cr	₹23 Cr	₹18 Cr	₹14 Cr	₹10 Cr	₹6 Cr	₹4 Cr	₹3 Cr
₹197 Cr	₹172 Cr	₹145 Cr	₹122 Cr	₹117 Cr	₹98 Cr	₹80 Cr	₹77 Cr	₹61 Cr	₹54 Cr	₹40 Cr	₹33 Cr	₹27 Cr	₹23 Cr	₹19 Cr	₹15 Cr	₹10 Cr	₹8 Cr	₹8 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹24 L	₹24 L	₹25 L	₹63,000	₹4 L	₹2 L	₹7 L	₹13 L	₹3 Cr	₹5 Cr	₹7 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹2 Cr	₹2 Cr	₹2 Cr
-₹1 Cr	-₹38 L	-₹81,000	₹29 L	₹48 L	₹8 L	₹24 L	-₹37 L	₹12 L	₹50 L	₹63 L	₹76 L	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹70 L	₹50 L	₹51 L
₹5 Cr	₹5 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹0	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹0	₹0	₹0
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹5 Cr	₹4 Cr	₹6 Cr	₹0	₹0	₹0
₹3 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹5 Cr	-₹37 L	₹3 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹9 Cr	₹8 Cr	₹9 Cr	₹6 Cr	₹7 Cr	₹10 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹8 Cr	₹8 Cr	₹6 Cr	₹6 Cr	₹7 Cr	₹5 Cr	₹5 Cr	₹7 Cr	₹4 Cr	₹6 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹4 Cr
₹7 Cr	₹7 Cr	₹8 Cr	₹7 Cr	₹8 Cr	₹8 Cr	₹9 Cr	₹11 Cr	₹9 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹44 L	₹2 Cr	₹37 L
₹0	₹2 Cr	₹0	₹2 Cr	₹6 Cr	₹4 Cr	₹3 Cr	₹7 Cr	₹53,000	₹6 Cr	₹5 Cr	₹7 Cr	₹2 Cr	₹5 Cr	₹2 Cr	₹2 Cr	₹0	₹0	₹0
₹8 Cr	₹2 Cr	₹3 Cr	₹59 L	₹34 L	₹1 Cr	₹3 Cr	₹63 L	₹36 L	₹70 L	₹93 L	₹9 Cr	₹3 Cr	₹5 Cr	₹5 Cr	₹2 Cr	₹5 Cr	₹4 Cr	₹3 Cr
₹23 Cr	₹19 Cr	₹16 Cr	₹16 Cr	₹21 Cr	₹18 Cr	₹20 Cr	₹25 Cr	₹13 Cr	₹18 Cr	₹14 Cr	₹24 Cr	₹13 Cr	₹18 Cr	₹14 Cr	₹12 Cr	₹11 Cr	₹10 Cr	₹8 Cr
₹224 Cr	₹195 Cr	₹164 Cr	₹141 Cr	₹143 Cr	₹120 Cr	₹104 Cr	₹103 Cr	₹78 Cr	₹76 Cr	₹58 Cr	₹61 Cr	₹44 Cr	₹49 Cr	₹40 Cr	₹36 Cr	₹27 Cr	₹26 Cr	₹26 Cr
₹17 Cr	₹16 Cr	₹17 Cr	₹20 Cr	₹17 Cr	₹17 Cr	₹17 Cr	₹17 Cr	₹17 Cr	₹17 Cr	₹7 L	₹3 Cr	₹0	₹4 L	₹72 L	₹76 L	₹29 L	₹48,000	₹0
₹0	₹2 Cr	₹0	₹2 Cr	₹6 Cr	₹4 Cr	₹3 Cr	₹7 Cr	₹24 L	₹6 Cr	₹5 Cr	₹7 Cr	₹2 Cr	₹5 Cr	₹2 Cr	₹2 Cr	₹5 Cr	₹7 Cr	₹10 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹47 Cr	₹40 Cr	₹34 Cr	₹34 Cr	₹33 Cr	₹32 Cr	₹31 Cr	₹27 Cr	₹26 Cr	₹25 Cr	₹26 Cr	₹23 Cr	₹24 Cr	₹23 Cr	₹21 Cr	₹17 Cr	₹13 Cr	₹12 Cr	₹11 Cr
₹28 Cr	₹26 Cr	₹23 Cr	₹24 Cr	₹22 Cr	₹21 Cr	₹20 Cr	₹17 Cr	₹16 Cr	₹15 Cr	₹13 Cr	₹12 Cr	₹11 Cr	₹9 Cr	₹8 Cr	₹7 Cr	₹6 Cr	₹5 Cr	₹5 Cr
₹19 Cr	₹15 Cr	₹10 Cr	₹10 Cr	₹11 Cr	₹11 Cr	₹12 Cr	₹10 Cr	₹10 Cr	₹11 Cr	₹12 Cr	₹12 Cr	₹14 Cr	₹14 Cr	₹13 Cr	₹10 Cr	₹7 Cr	₹6 Cr	₹6 Cr
₹46 Cr	₹40 Cr	₹1 Cr	₹96 L	₹21 L	₹38 L	₹12 L	₹99 L	₹0	₹0	₹0	₹0	₹0	₹0	₹24 L	₹52 L	₹1 Cr	₹97 L	₹0
₹27 Cr	₹21 Cr	₹17 Cr	₹11 Cr	₹8 Cr	₹7 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹61 L	₹31 L	₹31 L	₹31 L	₹53 L	₹79 L	₹57 L	₹48 L	₹39 L
₹27 Cr	₹21 Cr	₹17 Cr	₹11 Cr	₹8 Cr	₹7 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹61 L	₹31 L	₹31 L	₹31 L	₹53 L	₹79 L	₹57 L	₹48 L	₹39 L
₹26 L	₹2 Cr	₹25 Cr	₹12 Cr	₹11 Cr	₹32 L	₹29 L	₹17 L	₹10 L	₹26 L	₹0	₹0	₹33 L	₹0	₹0	₹0	₹0	₹0	₹0
₹36 Cr	₹61 Cr	₹82 L	₹26 Cr	₹36 Cr	₹23 Cr	₹13 L	₹18 L	₹25 L	₹25 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹129 Cr	₹138 Cr	₹55 Cr	₹60 Cr	₹67 Cr	₹40 Cr	₹15 Cr	₹13 Cr	₹12 Cr	₹13 Cr	₹13 Cr	₹12 Cr	₹14 Cr	₹15 Cr	₹14 Cr	₹12 Cr	₹9 Cr	₹8 Cr	₹6 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹0	₹0	₹0	₹0	₹0	₹25 L	₹2 Cr	₹4 Cr	₹4 Cr	₹55 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹14 Cr	₹9 Cr	₹9 Cr	₹8 Cr	₹10 Cr	₹8 Cr	₹11 Cr	₹10 Cr	₹7 Cr	₹11 Cr	₹8 Cr	₹8 Cr	₹7 Cr	₹8 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹7 Cr	₹7 Cr
₹24 Cr	₹21 Cr	₹19 Cr	₹17 Cr	₹15 Cr	₹14 Cr	₹18 Cr	₹23 Cr	₹13 Cr	₹9 Cr	₹6 Cr	₹7 Cr	₹5 Cr	₹6 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹5 Cr
₹53 Cr	₹25 Cr	₹79 Cr	₹54 Cr	₹49 Cr	₹57 Cr	₹58 Cr	₹52 Cr	₹41 Cr	₹42 Cr	₹30 Cr	₹28 Cr	₹17 Cr	₹11 Cr	₹8 Cr	₹6 Cr	₹4 Cr	₹3 Cr	₹3 Cr
₹1 Cr	₹1 Cr	₹96 L	₹97 L	₹73 L	₹63 L	₹85 L	₹79 L	₹80 L	₹63 L	₹1 Cr	₹6 Cr	₹75 L	₹9 Cr	₹8 Cr	₹8 Cr	₹0	₹0	₹0
₹3 Cr	₹98 L	₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹78 L	₹1 Cr	₹97 L	₹81 L	₹53 L	₹49 L	₹30 L	₹43 L	₹38 L	₹45 L	₹5 Cr	₹4 Cr	₹4 Cr
₹95 Cr	₹57 Cr	₹110 Cr	₹81 Cr	₹76 Cr	₹80 Cr	₹90 Cr	₹90 Cr	₹66 Cr	₹64 Cr	₹45 Cr	₹49 Cr	₹30 Cr	₹34 Cr	₹26 Cr	₹24 Cr	₹18 Cr	₹18 Cr	₹19 Cr
₹72 Cr	₹38 Cr	₹93 Cr	₹65 Cr	₹55 Cr	₹62 Cr	₹70 Cr	₹64 Cr	₹53 Cr	₹46 Cr	₹31 Cr	₹25 Cr	₹17 Cr	₹17 Cr	₹13 Cr	₹12 Cr	₹7 Cr	₹8 Cr	₹11 Cr
₹224 Cr	₹195 Cr	₹164 Cr	₹141 Cr	₹143 Cr	₹120 Cr	₹104 Cr	₹103 Cr	₹78 Cr	₹76 Cr	₹58 Cr	₹61 Cr	₹44 Cr	₹49 Cr	₹40 Cr	₹36 Cr	₹27 Cr	₹26 Cr	₹26 Cr
₹446	₹389	₹328	₹277	₹256	₹215	₹174	₹169	₹133	₹117	₹86	₹72	₹59	₹49	₹40	₹31	₹22	₹18	₹17
₹446	₹389	₹328	₹277	₹256	₹215	₹174	₹169	₹133	₹117	₹86	₹72	₹59	₹49	₹40	₹31	₹22	₹18	₹17

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008
₹47 Cr	₹44 Cr	₹35 Cr	₹33 Cr	₹30 Cr	₹22 Cr	₹21 Cr	₹27 Cr	₹25 Cr	₹20 Cr	₹17 Cr	₹14 Cr	₹10 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹6 Cr	₹3 Cr	₹2 Cr
-₹5 Cr	-₹3 Cr	-₹49 L	-₹2 Cr	-₹2 Cr	-₹2 Cr	-₹1 Cr	-₹2 Cr	-₹2 Cr	-₹74 L	-₹50 L	₹98 L	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr
-₹3 Cr	₹49 L	-₹18 Cr	-₹6 Cr	-₹11 Cr	₹5 Cr	₹57 L	-₹5 Cr	₹97 L	-₹3 Cr	-₹3 Cr	-₹2 Cr	₹2 Cr	-₹2 Cr	₹25 L	₹46 L	₹2 Cr	₹3 Cr	-₹1 Cr
₹38 Cr	₹41 Cr	₹16 Cr	₹25 Cr	₹17 Cr	₹25 Cr	₹20 Cr	₹20 Cr	₹25 Cr	₹17 Cr	₹14 Cr	₹13 Cr	₹14 Cr	₹8 Cr	₹10 Cr	₹11 Cr	₹9 Cr	₹7 Cr	₹2 Cr
₹27 Cr	₹28 Cr	₹8 Cr	₹17 Cr	₹9 Cr	₹19 Cr	₹15 Cr	₹13 Cr	₹16 Cr	₹10 Cr	₹8 Cr	₹9 Cr	₹11 Cr	₹5 Cr	₹7 Cr	₹7 Cr	₹5 Cr	₹4 Cr	₹54 L
-₹19 Cr	-₹17 Cr	-₹58 L	₹3 Cr	-₹1 Cr	-₹19 Cr	-₹3 Cr	-₹11 Cr	₹100 L	-₹10 Cr	-₹27 L	₹1 Cr	₹45 L	-₹1 Cr	-₹3 Cr	-₹3 Cr	-₹59 L	-₹97 L	-₹18 L
-₹9 Cr	-₹8 Cr	-₹7 Cr	-₹21 Cr	-₹6 Cr	-₹71 L	-₹11 Cr	-₹2 Cr	-₹18 Cr	₹68 L	-₹5 Cr	₹83 L	-₹7 Cr	₹8 L	-₹2 Cr	-₹2 Cr	-₹4 Cr	-₹4 Cr	-₹15 L
-₹2 Cr	₹3 Cr	₹47 L	-₹1 Cr	₹3 Cr	-₹4 L	₹1 Cr	₹4 L	-₹80 L	₹86 L	₹2 Cr	₹11 Cr	₹5 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹44 L	-₹10 L	₹20 L
₹7 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹2 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹28 Cr	₹17 Cr	₹11 Cr	₹8 Cr	₹6 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr
₹6 Cr	₹7 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹2 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹30 Cr	₹28 Cr	₹17 Cr	₹11 Cr	₹8 Cr	₹6 Cr	₹4 Cr	₹3 Cr	₹3 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Jenburkt Pharmaceuticals Share Price

900.00+40.00 (+4.65%)

-29.30% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Open a free Demat account in minutes to start investing and screening .

Jenburkt Pharmaceuticals Share Price

900.00+40.00 (+4.65%)

-29.30% past 1 Year

Shareholding summary

Promoters

46.62%

FII

DII

0.03%

Others

53.35%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
46.62%	46.62%	46.64%	46.65%	46.66%	46.67%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.03%	0.12%	0.12%	0.12%	0.12%	0.12%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
53.35%	53.26%	53.24%	53.23%	53.22%	53.21%

Bulk & block deals

Name

Jenburkt Pharmaceuticals Ltd

Aries Stocktrades Pvt Ltd A/C-Pms

Trupti Ketan Karani

Ketan Jayantilal Karani (Huf)

Girik Wealth Advisors Private Limited-Deep Value Pms

Aries Stocktrades Pvt Ltd A/C-Pms

Dinero Wealth Advisors Private Limited

Kaushik Paraskumar Daga

Dinero Wealth Advisors Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
06 Jan 2023	Purchase	3.06 Cr	₹649.97	47.04 K	Bulk	1.065801	BSE
25 Aug 2020	Sell	1.07 Cr	₹410.39	26 K	Bulk	0.589128	BSE
08 Feb 2018	Sell	1.41 Cr	₹540.50	26 K	Bulk	0.589128	BSE
08 Feb 2018	Purchase	1.41 Cr	₹540.50	26 K	Bulk	0.589128	BSE
05 Sep 2017	Sell	1.33 Cr	₹433.26	30.79 K	Bulk	0.697755	BSE
04 Nov 2016	Purchase	1.34 Cr	₹566.67	23.59 K	Bulk	0.534543	BSE
30 Jan 2015	Sell	1.04 Cr	₹347.03	30 K	Bulk	0.679763	BSE
30 Jan 2015	Purchase	1.04 Cr	₹347.12	30 K	Bulk	0.679763	BSE
30 Jul 2014	Purchase	53.84 L	₹187.95	28.65 K	Bulk	0.649083	BSE
21 Jul 2014	Purchase	59.11 L	₹219.48	26.93 K	Bulk	0.610292	BSE

Insider trading & SAST

Client name

Prakash H. Bhuta

Prakash Bhuta

Mahesh H Bhuta

Riddhi Haresh Shroff

Riddhi Haresh Shroff & Pacs

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
14 Jun 2024	Promoter Group	Disposal	0.463893	0	1.65 Cr	₹804.79	20.47 K	10 Jun 2024 - 12 Jun 2024	Market Sale	0	Insider Trading	—	Equity Shares
27 Mar 2024	Promoter Group	Disposal	0.134389	0.53	41.65 L	₹702.21	5.93 K	18 Mar 2024 - 22 Mar 2024	Market Sale	23,481	Insider Trading	—	Equity Shares
10 Jul 2023	Promoter Group	Disposal	0.022659	1.66	7.16 L	₹716.05	1 K	07 Jul 2023	Market Sale	73,374	Insider Trading	—	Equity Shares
10 Jul 2023	Promoter Group	Disposal	0.056647	1.63	0	—	2.50 K	05 Jul 2023	Off Market	71,874	Insider Trading	—	Equity Shares
10 Jul 2023	Promoter Group	Acquisition	0.056647	1.67	0	—	2.50 K	05 Jul 2023	Off Market	74,374	Insider Trading	—	Equity Shares
29 May 2023	Promoter Group	Acquisition	0.333243	0.73	0	—	14.71 K	25 Apr 2023 - 26 Apr 2023	Off Market	32,240	Insider Trading	—	Equity Shares
29 May 2023	Promoter Group	Disposal	0.333243	0.4	0	—	14.71 K	25 Apr 2023 - 26 Apr 2023	Off Market	17,533	Insider Trading	—	Equity Shares
26 Apr 2023	Promoter Group	Disposal	0.333243	0.4	0	—	14.71 K	25 Apr 2023 - 26 Apr 2023	Off Market	17,533	Insider Trading	—	Equity Shares
26 Apr 2023	Promoter Group	Acquisition	0.333243	0.73	0	—	14.71 K	25 Apr 2023 - 26 Apr 2023	Off Market	32,240	Insider Trading	—	Equity Shares
26 Dec 2022	Promoter	Acquisition	0.64	45.73	0	—	29.41 K	25 Oct 2022	Transmission	20,98,788	SAST	29(1)	—

Jenburkt Pharmaceuticals Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Jenburkt Pharmaceuticals Share Price

Jenburkt Pharmaceuticals Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Jenburkt Pharmaceuticals Share Price

Jenburkt Pharmaceuticals Share Price

Oscillators

Moving averages

Jenburkt Pharmaceuticals Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Jenburkt Pharmaceuticals Share Price

Corporate Actions

Company details

Jenburkt Pharmaceuticals Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Jenburkt Pharmaceuticals Share Price

News

Jenburkt Pharma reports Profit after tax of 10.85 Crores, in the March 2026 quarter

Jenburkt Pharmaceuticals informs about annual disclosure

Jenburkt Pharma - Quaterly Results

Jenburkt Pharma reports Profit after tax of 5.93 Crores, in the December 2025 quarter

Jenburkt Pharma - Quaterly Results

Jenburkt Pharmaceuticals informs about unaudited financial results

Jenburkt Pharma reports Profit after tax of 10.16 Crores, in the September 2025 quarter

Jenburkt Pharma reports Profit after tax of 7.79 Crores, in the June 2025 quarter

Jenburkt Pharma - Quaterly Results

Jenburkt Pharma - Quaterly Results

Jenburkt Pharma - Quaterly Results

Jenburkt Pharmaceuticals informs about newspaper publication

Jenburkt Pharma reports Profit after tax of 8.54 Crores, in the March 2025 quarter

Jenburkt Pharma - Quaterly Results

Jenburkt Pharma - Quaterly Results

Jenburkt Pharmaceuticals informs about closure of trading window

Jenburkt Pharma reports Profit after tax of 6.51 Crores, in the December 2024 quarter

Jenburkt Pharma - Quaterly Results

Jenburkt Pharma - Quaterly Results

Jenburkt Pharma - Quaterly Results

Jenburkt Pharmaceuticals Ltd Share Price Today

Jenburkt Pharmaceuticals Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator